Ipca's operating margin climbs to 24.01% as revenue growth outpaces costs
Net profit rose 82.18% YoY, helped by a lower tax rate and reduced interest costs.
Filed 13 Aug 2026, 13:35 IST · Ipca Laboratories Ltd (IPCALAB)
Key takeaways
- Consolidated operating margin rose 5.97 percentage points YoY to 24.01% as revenue grew 20.76% while expenses grew 11.95%.
- Consolidated net profit increased 82.18% YoY to Rs 424.27 cr, helped by a 3.18 percentage-point lower tax rate and 35.82% lower interest.
- The stock has fallen after six of its eight recent results, with a median absolute move of 3.05%.
Price around the results
Revenue rebound lifts quarterly profit
Consolidated revenue grew 20.76% YoY to Rs 2,788.1 cr and 16.73% QoQ, while operating profit rose 60.78% YoY and 38.37% QoQ. Net profit increased 82.18% YoY to Rs 424.27 cr, with EPS rising 72.36% YoY to Rs 15.84. The QoQ improvement also accelerated, with net profit up 38.34%.
Operating leverage drove the margin expansion
Expenses grew 11.95% YoY against 20.76% revenue growth, lifting operating margin by 5.97 percentage points; the QoQ margin gain was 3.75 percentage points as revenue growth also outpaced expense growth. Interest fell 35.82% YoY and 41.19% QoQ, supporting profit before tax. The YoY tax rate was 3.18 percentage points lower, so the net-profit increase received a tax benefit, while the QoQ tax rate rose 2.37 percentage points.
Margin trend recovers from the Q4FY26 dip
Operating margin improved from 18.04% in Q1FY26 to 21.32% in Q2FY26 and 22.29% in Q3FY26, before slipping to 20.26% in Q4FY26 and recovering to 24.01% this quarter. Other income was only 4.66% of pre-tax profit, so the quarter's profit was mainly supported by operating performance rather than non-operating income. Ipca's margin was 1.06 percentage points above the 22.95% median among 69 Healthcare peers that had reported.
Past result-day moves have mostly been negative
The stock has declined after six of its eight recent results, against two gains, with a median absolute move of 3.05%. The latest result has no reported market reaction yet, so its eventual move can be compared with that recent pattern.
Q1FY27 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q1FY27 | Q4FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹2,788 cr | ₹2,388 cr | +16.73% | +20.76% |
| Other income | ₹27 cr | ₹45 cr | -40.90% | -14.17% |
| Expenses | ₹2,119 cr | ₹1,905 cr | +11.23% | +11.95% |
| Operating profit | ₹670 cr | ₹484 cr | +38.37% | +60.78% |
| Operating margin (%) | 24.01% | 20.26% | — | — |
| Interest | ₹12 cr | ₹20 cr | -41.19% | -35.82% |
| Depreciation | ₹111 cr | ₹107 cr | +3.43% | +10.74% |
| Profit before tax | ₹574 cr | ₹402 cr | +42.76% | +74.34% |
| Tax | ₹149 cr | ₹95 cr | +57.04% | +55.34% |
| Net profit | ₹424 cr | ₹307 cr | +38.34% | +82.18% |
| EPS (₹) | ₹15.84 | ₹11.79 | +34.35% | +72.36% |
Operating margin of 24.01% compares with a Healthcare sector median of 22.95% across 69 peers that have reported Q1FY27.
What to watch
- Whether operating margin holds above 24.01% after the Q1FY27 recovery.
- Whether revenue growth remains ahead of expense growth, after the current 20.76% versus 11.95% YoY gap.
- Whether the tax rate stays near or below the current 26.03%.